Related Experiment Video
Updated: Nov 25, 2025
07:35
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
42.2K
Hepatic Metastasis from Breast Cancer
Ariel N Liberchuk1, Amy R Deipolyi1
1Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Seminars in Interventional Radiology
|December 17, 2020
Summary
Locoregional therapies may improve outcomes for breast cancer liver metastasis. Further research is needed to confirm benefits and guide patient selection for these treatments.
Area of Science:
- Oncology
- Hepatology
Background:
- Breast cancer is the most common cancer in women.
- Liver metastasis from breast cancer is associated with poor patient prognosis.
- Locoregional therapies offer potential for managing breast cancer liver metastasis.
Purpose of the Study:
- To review existing retrospective studies on the benefits of locoregional treatment for breast cancer liver metastasis.
- To highlight the potential of these therapies in improving outcomes for patients with liver metastases.
Main Methods:
- Review of retrospective studies.
- Analysis of data on locoregional treatment efficacy.
Main Results:
- Retrospective data suggest potential benefits of locoregional therapies.
- These treatments may offer local control, improve quality of life, preserve liver function, and potentially prolong survival.
Conclusions:
- Locoregional therapies show promise for treating breast cancer liver metastasis.
- Prospective studies are essential to validate efficacy and refine patient selection criteria.
